Luo Da, Wang Xiaoying, Wang Liyue, Hu Zheng, Zhang Bofang, Xu Changwu, Jiang Hong, Chen Jing
Department of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan, 430060, People's Republic of China.
Cardiovascular Research Institute of Wuhan University, Wuhan, People's Republic of China.
Sci Rep. 2025 Apr 1;15(1):11075. doi: 10.1038/s41598-025-93379-6.
The systemic inflammation tends to increase progressively as kidney function deteriorates. However, it remains unknown whether mild renal insufficiency affects inflammatory response at admission and subsequent clinical outcomes following ST-segment elevation myocardial infarction (STEMI). This study aimed to evaluate the joint, interactive, and mediating effects of estimated glomerular filtration rate (eGFR) and neutrophil-lymphocyte ratio (NLR) at admission on 1-year mortality in STEMI patients. Data were collected from 5,594 consecutive STEMI patients at seven centers (NCT04996901). Mildly reduced eGFR (60-89 mL/min/1.73m) was associated with both elevated NLR and increased 1-year mortality (β 0.55, 95%CI [0.07-1.02], P = 0.024; HR 2.18, 95%CI [1.55-3.08], P < 0.001; respectively). Inflammation at admission mediated a small but significant proportion of the association between mildly reduced eGFR and mortality risk (1.7%, P = 0.030). Incorporating eGFR and NLR into a predictive model significantly improved mortality prediction following STEMI compared with clinical risk factors alone (C-index, 0.799 vs. 0.730, P < 0.001; net reclassification index 0.334, P < 0.001). These findings support the identification of patients at risk who may benefit from intensive kidney function monitoring and early adjuvant intervention, while also highlighting the need for developing anti-inflammatory therapies for STEMI patients with renal insufficiency.
随着肾功能恶化,全身炎症往往会逐渐加重。然而,轻度肾功能不全是否会影响ST段抬高型心肌梗死(STEMI)患者入院时的炎症反应及随后的临床结局仍不清楚。本研究旨在评估入院时估计肾小球滤过率(eGFR)和中性粒细胞与淋巴细胞比值(NLR)对STEMI患者1年死亡率的联合、交互及中介作用。数据来自7个中心的5594例连续STEMI患者(NCT04996901)。轻度降低的eGFR(60-89 mL/min/1.73m²)与NLR升高和1年死亡率增加均相关(β 0.55,95%CI [0.07-1.02],P = 0.024;HR 2.18,95%CI [1.55-3.08],P < 0.001;分别)。入院时的炎症介导了轻度降低的eGFR与死亡风险之间小但显著比例的关联(1.7%,P = 0.030)。与仅使用临床危险因素相比,将eGFR和NLR纳入预测模型显著改善了STEMI后的死亡率预测(C指数,0.799对0.730,P < 0.001;净重新分类指数0.334,P < 0.001)。这些发现支持识别可能从强化肾功能监测和早期辅助干预中获益的高危患者,同时也强调了为肾功能不全的STEMI患者开发抗炎治疗的必要性。